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Abstract
Purpose To compare mid-term clinical outcomes of two
revision strategies for patients with failed SB Charite´ III
total disc replacements (TDRs).
Methods Eighteen patients with a failed TDR underwent
posterolateral instrumented fusion (fusion group); in 21
patients, the TDR was removed and the intervertebral
defect was filled with a bone strut graft, followed by an
instrumented posterolateral fusion (removal group). Visual
analogue scale (VAS) for pain and Oswestry Disability
Index (ODI) were completed pre- and post-revision sur-
gery. Intra- and post-operative complications of both
revision strategies were assessed.
Results Mean follow-up was 3.7 years (range 1.0–6.4) in
the removal group and 4.4 years (range 0.7–11.0) in the
fusion group. Although the removal group showed a sig-
nificantly lower VAS and ODI score post-revision surgery
as compared to preoperative (P \ 0.01 and P = 0.01,
respectively), no significant differences were found
between the removal and fusion groups before and after
revision surgery in VAS and ODI. A clinical relevant
improvement in VAS and ODI was found in 47 and 21 %
respectively in the removal group, and in 22 and 27 %
respectively in the fusion group. Substantial complications
were observed only in the removal group.
Conclusions Both procedures showed improvement
clinically. There were no significant additional benefits of
removing the TDR as compared to fusion alone at mid-
term follow-up. The clinical decision to remove the TDR
should be carefully weighed up against potential risks and
complications of this procedure.
Keywords Total disc replacement  Spinal fusion 
Revision surgery  VAS  Oswestry
Introduction
Lumbar total disc replacement (TDR) is increasingly used
in the surgical treatment of degenerative disc disease
(DDD). TDR aims to remove the pain source while pre-
serving vertebral motion at the degenerative operated
level(s) to prevent the development of adjacent segment
degeneration [1–6]. The debate whether TDR is more
effective than lumbar spinal fusion in treating DDD is still
going on [5, 7–12]. Recently, a prospective randomized
study showed that there are no differences in safety and
clinical outcomes after TDR as compared to spinal fusion,
at a follow-up period of 5 years [8]. It was further reported
that between 2 and 5-years follow-up, only in the TDR
group device failures had been observed [8].
Potential complications after TDR are recurrent back
and leg pain, caused by facet joint degeneration, subsi-
dence, polyethylene wear, migration and adjacent segment
degeneration [5, 7, 10, 13]. This warrants the need for
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surgical revision strategies [14]. In a recent systematic
review of Eerenbeemt et al. [11], an overall revision sur-
gery rate ranging from 3.7 to 11.4 % was found after TDR.
An important question we should ask ourselves is: Will
revision surgery be beneficial, and if so, what would be the
best revision strategy for failed TDR? In a previous study,
we reported short-term results of two revision strategies
with a follow-up of 1 year, showing that TDR removal
gave better results than posterolateral instrumented fusion
alone [15]. Larger groups and longer follow-up were
thought to be necessary to support possible advantages of
TDR removal surgery.
The purpose of this study was to compare the clinical mid-
term results of these two revision strategies for patients with
a failed SB Charite´ III lumbar disc prosthesis. Posterolateral
instrumented fusion alone was compared with TDR removal




Ninety patients with a SB Charite´ III TDR (Waldemar
Link, Germany; DePuy Spine, Raynham, MA, USA) were
seen in the outpatient clinic. For all these patients TDR
implantation had been performed elsewhere. After
evaluation, in 39 patients one or more revision surgeries
were performed. Indications for revision surgery were
recurrent back and leg pain, and the presence of a TDR-
related pathology such as facet joint degeneration, subsi-
dence and migration as observed on plain radiographs, CT-
scan and/or MRI (Table 1). Adjacent disc degeneration
was observed in 13 patients; however, it is uncertain
whether this is caused as a consequence of the TDR.
In 21 patients, the TDR was removed and after clearing of
periprosthetic fibrous tissue and sclerotic bone, the inter-
vertebral defect was filled with a bone strut graft. In addition,
an instrumented posterolateral fusion was performed [16]
(removal group). In the 18 other patients, posterolateral
instrumented fusion without removal was performed (fusion
group). The surgical technique of both surgeries was
described in detail by de Maat et al. [16]. Because of per-
sisting pain, in 8 of these 18 patients TDR removal was
performed several years later as a second stage revision
surgery (range 1.5–7.5 years). For these eight patients, data
were available before and after fusion (stage 1) as well as
before and after removal of the TDR (stage 2). An overview
of the included patients is shown in Fig. 1.
Clinical outcome measurements and complications
For all patients clinical evaluations were available pre- and
post-revision surgery. These evaluations included a 10-point
visual analogue scale (VAS) for pain and Oswestry
Table 1 Summary of patient
and clinical variables for TDR
removal and fusion only group
TDR removal (n = 21) Fusion only (n = 18) P value
Sex (male:female) 15:6 10:8 0.31
Mean age insertion TDR 43.4 (range 32–56) 40.7 (range 30–63) 0.11








L4–L5, L5–S1 4 4
3 level




Facet joint degeneration 10 14
Breakage metal wire 2 4
Osteolysis 0 1
Adjacent disc degeneration 5 8
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Disability Index (ODI, 0–100 points) questionnaire.
According to the FDA-criteria, clinical success was defined
as a C25 % improvement in ODI between pre- and post-
revision surgery [1]. Similarly for the VAS pain score, a
C25 % improvement was considered as clinically success-
ful. In addition, intra- and post-operative complications of
both revision strategies were assessed.
Statistical analysis
Analyses were performed using SPSS 16. Non parametric
tests, i.e. Mann–Whitney and Wilcoxon, were used to test
the mean. The mean values were given along ±standard
error of the mean (SEM); P values \0.05 were considered
statistically significant.
Results
There were no significant differences between the removal
group (n = 21) and fusion group (n = 18) with respect to
sex, age at insertion of the TDR, mean time in situ of the
TDR and number of operated levels (Table 1).
The mean follow-up in the removal group was 3.7 years
(range 1.0–6.4 years) and 4.4 years (range 0.7–11.0 years)
in the fusion group (P = 0.82).
VAS pain scores
The mean ± SEM (standard error of the mean) pre-revi-
sion surgery VAS score was 7.9 ± 0.3 in the removal
group and 7.8 ± 0.2 in the fusion group (P = 0.33). Post-
revision VAS scores were 6.0 ± 0.4 and 7.0 ± 0.4 in the
removal group and in the fusion group, respectively
(P = 0.09). In both groups, a substantially lower VAS
score was observed after revision surgery. Only in the
removal group, there was a significant decrease in VAS
score at post-revision surgery compared to pre-revision
surgery (P \ 0.01) (Fig. 2a).
The percentage of improvement after revision surgery in
both groups is shown in Fig. 3a. According to the above-
mentioned FDA-criteria, in which an improvement of
C25 % was considered to be clinically successful, 10 out
of 21 patients (47.6 %) in the removal group and 4 out of
A
B
n=21 n=18 n=21 n=18
p<0.01
n=21 n=18 n=21 n=18
p=0.01
Fig. 2 a Mean VAS scores for both groups pre- and post-revision
surgery. b Mean Oswestry Disability Index for both groups during











Stage 1 Stage 2
Fig. 1 Overview of the patients who underwent revision surgery after
TDR implantation. In these eight patients, pre- as well as post-
revision surgery data were available for the fusion and removal
revision surgeries (asterisk)
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18 patients (22.2 %) in the fusion group were clinically
improved (P = 0.14).
Oswestry Disability Index
The mean pre- and post-revision surgery ODI scores were
similar between the removal and fusion groups (P = 0.57,
P = 0.61, respectively). The ODI in the removal group
improved from 53.2 (±3.3) to 44.5 (±3.8) (P = 0.01), and
in the fusion group from 57.3 (±3.9) to 48.2 (±4.6)
(P = 0.06) (Fig. 2b).
The percentage of improvement after revision surgery in
both groups is shown in Fig. 3b. A clinically relevant
improvement of[25 % was present in 4 out of 21 patients
(21.1 %) in the removal group and in 5 out of 18 patients
(27.8 %) in the fusion group were clinically improved
(P = 0.69).
Second stage revision surgery
In the fusion group, the eight patients with persisting
symptoms who underwent TDR removal at a later time-
point as a second stage revision surgery had a mean follow-
up period of 3.1 years (range 0.7–7.3) after fusion, while
the other 10 patients had a mean follow-up of 5.6 years
(range 1.8–11.0, P = 0.01). From the abovementioned
eight patients, a mean follow-up of 3.1 years (range
Fig. 3 Box plot with a percentage change in VAS score in both
revision strategy groups during pre- and post-revision surgery,
b percentage change in ODI score in both revision strategy groups
during pre- and post-revision surgery. The line represents a clinical




n=10 n=8     n=8
n=10 n=8 n=8
Fig. 4 a Mean VAS scores for the fusion subgroups. b Mean
Oswestry Disability Index scores for the fusion subgroups. Of the 18
patients, eight patients underwent TDR removal as a second revision
surgery. The error bars represent standard error of the mean
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1.4–5.0) was available after their second stage revision
surgery, TDR removal.
In the fusion group, there was a significant difference in
post-revision surgery VAS score between the patients who
underwent TDR removal at a later time-point (n = 8) and
those who did not (n = 10) (P \ 0.01). The patient group
who underwent removal as a second stage revision surgery
(n = 8) had a decreased VAS score of 8.1 ± 0.4 to
6.7 ± 0.5 in time (P = 0.06) (Fig. 4a).
Patients in the fusion group who would undergo removal
as a second stage revision had a similar ODI score as those
who would not (P = 0.60 post-revision surgery stage 1).
The patient group who underwent removal as a second
revision surgery (n = 8) had a ODI score of 52.3 ± 7.3
and 56.8 ± 5.7 after stage 1 and stage 2 revision surgery,
respectively (Fig. 4b).
Complications
An overview of the intra- and post-operative complications
from both revision procedures is shown in Table 2. Intra-
operatively, no complications were seen in the fusion group,
whereas in the removal group different types of vessel
bleeding (n = 6), a small colon lesion (n = 1) and decreased
sensitivity of the groyne (n = 2) were observed. In one
patient TDR removal was planned, however, due to an intra-
operative rupture of the small intestine this procedure was
abandoned and only posterior fusion was performed. This
patient was thus included in the fusion group. In one patient a
lesion of the ureter occurred intra-operatively which neces-
sitated resection of the left kidney at a second stage. In the
fusion only group two patients developed a pseudo-arthrosis.
Discussion
The clinical results of two revision strategies for failed
TDR’s were studied after a mean follow-up of 3.7 and
4.4 years in the removal and fusion group, respectively. In
18 patients, a posterolateral instrumented fusion without
removal was performed and in 21 patients removal of the
TDR was combined with anterior interbody fusion fol-
lowed by posterolateral instrumented fusion. The mid-term
VAS and ODI scores significantly improved in the removal
group compared to pre-revision surgery, while no signifi-
cant improvement was found in the fusion group. However,
the VAS and ODI scores were comparable for both groups
at both time points. A clinical successful improvement
(C25 %) in VAS was found in 47 % in the removal group
and in 22 % in the fusion group. For ODI, 21 % in the
removal group and 27 % in the fusion group showed a
clinical successful improvement. An important point to
consider is that, in contrast to the fusion only group with no
intra-operative complications, the TDR removal group
showed substantial complications in nine patients (31 %)
during surgery.
The present study was limited by the relatively small
number of cases in both groups which may have induced a
type II error. In addition, both surgical groups showed
heterogeneous patient characteristics. For example, the
number of patients who underwent a second stage revision
surgery varies considerably.
In the literature, a wide range of complications has been
reported in TDR implantation studies. These complications
can be divided into (1) treatment related (e.g. pain, wound
problems), (2) anterior approach related (e.g. vascular
injury, retrograde ejaculation) and (3) prosthesis related
(e.g. subsidence, migration) [11]. The number of reopera-
tions varied between 2.3 and 14 % [1, 6, 7, 11, 12, 17].
McAfee et al. [6] reported on 24 patients (9 %) who
underwent an anterior TDR revision surgery. Those
patients who underwent a revision for failed TDR, all had a
suboptimal or poor placement of the TDR. The mean time
to revision was 9 months (range 3 days to 34 months). In 4
of these 24 patients (16.7 %), a vascular injury was
encountered [6]. In another study, from Leary et al. [17], 18
Table 2 Intra- and post-
operative complications
resulting from both revision
strategies
TDR removal (n = 21) Fusion only (n = 18)
Intra-operative Left common iliac artery lesion (n = 1)
Left common iliac vein lesions (n = 2), one
resulting
in a deep venous thrombosis of the left leg
Bleeding ascending lumbar vein (n = 1)
Pronounced bleeding intervertebral defect (n = 1)
Major blood loss (5,100 cc) (n = 1)
Small colon lesion (n = 1)
Decreased sensitivity in the left groyne (n = 2)
Post-operative:
0–3 years
Resection left kidney after ureter lesion (n = 1) Pseudo-arthrosis
(n = 2)
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patients underwent an anterior revision procedure after an
average follow-up of 6 months (range 9 days to 4 years).
No significant vascular, ureteral and neurological injuries
were encountered. However, two patients had a minor left
iliac vein injury (11.1 %), and one case of retrograde
ejaculation was seen that resolved spontaneously [17]. In
our patient group we encountered a vascular injury in 6 out
of 29 (20.7 %). To avoid a ureter lesion, we suggest to
insert a J-catheter in the left ureter if a left retroperitoneal
approach is used. When considering revision surgery it
should be realized that removal of the prosthesis has
increased risks because of vascular structures and scar
tissue [16–18]. The assistance of a vascular surgeon during
TDR removal surgery is strongly recommended [16, 17].
Furthermore, the time between TDR implantation and
revision may be of importance. In our patients, TDR
removal was performed at much larger follow-up as com-
pared to the previously mentioned studies (mean 9.4 years,
range 3.1–16.3). When TDR removal is indicated, it should
be performed as soon as possible after the initial TDR
implantation because of the development of scar tissue and
adhesions [17]. Complications such as wound infection and
injury to the (superior) hypogastric plexus, which may
induce erectile dysfunction and retrograde ejaculation,
were not encountered in our series [19].
There is an ongoing discussion about the optimal revi-
sion strategy for failed TDRs. In case of an acceptable
implant status and position, posterior fusion can be
addressed for the treatment of recurrent back pain thought
to be facet joint in origin. When the TDR has subsided,
migrated or mechanically failed, the pain can be addressed
by TDR removal. In our own experience, the results of
posterolateral fusion without TDR removal were disap-
pointing in most patients. Therefore, we combined fusion
with TDR removal in all cases if the patient accepted the
risks of retrieval surgery.
In a previous study, we studied periprosthetic fibrous
tissues of the first 16 patients with TDR removal using
light microscopy [13]. Results of that study demonstrated
the presence of polyethylene wear particles and of peri-
prosthetic inflammatory reactions around a failed TDR in
15 out of 16 patients [13]. We therefore hypothesized that
TDR removal will reduce back and leg pain in failed
TDRs because the source of wear debris generation is
removed, which may diminish inflammatory mediated
pain. The present study showed that, although there was
no significant difference between the removal and fusion
group during post-revision surgery, the VAS score
improved significantly in the removal group after
3.1 years. Removal surgery as a second revision strategy
in patients who still experience a high amount of pain
after posterolateral fusion reduced VAS pain scores non-
significantly.
The aim of the present study was to provide mid-term
clinical follow-up data on two TDR revision strategies. In
agreement with our previous study [15], the VAS and ODI
scores showed similar wide ranges, which indicate sub-
stantial variability in outcome between the individual
patients. Possible explanations for these wide intervals are
patient-related factors like number of previous surgeries
and number of affected levels. Larger groups will be nec-
essary to assess the effect of patient factors on the success
rate of a revision surgery.
In conclusion, the benefit of removing the prosthesis
after failed TDR remains unclear. Removal of the TDR
may be justified. However, the patient should be counselled
about potential risks and complications of this kind of
revision surgery which should be carefully weighed up
against the possible benefits of TDR removal.
Conflict of interest None of the authors has any potential conflict of
interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Blumenthal S, McAfee PC, Guyer RD, Hochschuler SH, Geisler
FH, Holt RT, Garcia R, Jr., Regan JJ, Ohnmeiss DD (2005) A
prospective, randomized, multicenter Food and Drug Adminis-
tration investigational device exemptions study of lumbar total
disc replacement with the CHARITE artificial disc versus lumbar
fusion: part I—evaluation of clinical outcomes. Spine 30
(14):1565–1575 (discussion E1387–E1591)
2. McAfee PC, Cunningham B, Holsapple G, Adams K, Blumenthal
S, Guyer RD, Dmietriev A, Maxwell JH, Regan JJ, Isaza J (2005)
A prospective, randomized, multicenter Food and Drug Admin-
istration investigational device exemption study of lumbar total
disc replacement with the CHARITE artificial disc versus lumbar
fusion: part II—evaluation of radiographic outcomes and corre-
lation of surgical technique accuracy with clinical outcomes.
Spine 30(14):1576–1583 (discussion E1388–E1590)
3. de Kleuver M, Oner FC, Jacobs WC (2003) Total disc replace-
ment for chronic low back pain: background and a systematic
review of the literature. Eur Spine J 12(2):108–116
4. Geisler FH, Guyer RD, Blumenthal SL, McAfee PC, Cappuccino
A, Bitan F, Regan JJ (2008) Effect of previous surgery on clinical
outcome following 1-level lumbar arthroplasty. J Neurosurg
8(2):108–114
5. Lemaire JP, Carrier H, el Sariali H, Skalli W, Lavaste F (2005)
Clinical and radiological outcomes with the Charite artificial disc: a
10-year minimum follow-up. J Spinal Disord Tech 18(4):353–359
6. McAfee PC, Geisler FH, Saiedy SS, Moore SV, Regan JJ, Guyer
RD, Blumenthal SL, Fedder IL, Tortolani PJ, Cunningham B
(2006) Revisability of the CHARITE artificial disc replacement:
analysis of 688 patients enrolled in the U.S. IDE study of the
CHARITE artificial disc. Spine 31(11):1217–1226
7. David T (2007) Long-term results of one-level lumbar arthro-
plasty: minimum 10-year follow-up of the CHARITE artificial
disc in 106 patients. Spine 32(6):661–666
Eur Spine J (2012) 21:2558–2564 2563
123
8. Guyer RD, McAfee PC, Banco RJ, Bitan FD, Cappuccino A,
Geisler FH, Hochschuler SH, Holt RT, Jenis LG, Majd ME,
Regan JJ, Tromanhauser SG, Wong DC, Blumenthal SL (2009)
Prospective, randomized, multicenter Food and Drug Adminis-
tration investigational device exemption study of lumbar total
disc replacement with the CHARITE artificial disc versus lumbar
fusion: five-year follow-up. Spine J 9(5):374–386
9. Guyer RD, McAfee PC, Hochschuler SH, Blumenthal SL, Fedder
IL, Ohnmeiss DD, Cunningham BW (2004) Prospective ran-
domized study of the Charite artificial disc: data from two
investigational centers. Spine J 4(6 Suppl):252S–259S
10. Putzier M, Funk JF, Schneider SV, Gross C, Tohtz SW, Khoda-
dadyan-Klostermann C, Perka C, Kandziora F (2006) Charite total
disc replacement—clinical and radiographical results after an
average follow-up of 17 years. Eur Spine J 15(2):183–195
11. van den Eerenbeemt KD, Ostelo RW, van Royen BJ, Peul WC,
van Tulder MW (2010) Total disc replacement surgery for
symptomatic degenerative lumbar disc disease: a systematic
review of the literature. Eur Spine J 19(8):1262–1280
12. Yajun W, Yue Z, Xiuxin H, Cui C (2010) A meta-analysis of
artificial total disc replacement versus fusion for lumbar degen-
erative disc disease. Eur Spine J 19(8):1250–1261
13. Punt IM, Cleutjens JP, de Bruin T, Willems PC, Kurtz SM, van
Rhijn LW, Schurink GW, van Ooij A (2009) Periprosthetic tissue
reactions observed at revision of total intervertebral disc arthro-
plasty. Biomaterials 30(11):2079–2084
14. Cunningham BW, Hu N, Beatson HJ, Serhan H, Sefter JC,
McAfee PC (2009) Revision strategies for single- and two-level
total disc arthroplasty procedures: a biomechanical perspective.
Spine J 9(9):735–743
15. Punt IM, Visser VM, van Rhijn LW, Kurtz SM, Antonis J,
Schurink GW, van Ooij A (2008) Complications and reoperations
of the SB Charite lumbar disc prosthesis: experience in 75
patients. Eur Spine J 17(1):36–43
16. de Maat GH, Punt IM, van Rhijn LW, Schurink GW, van Ooij A
(2009) Removal of the Charite lumbar artificial disc prosthesis:
surgical technique. J Spinal Disord Tech 22(5):334–339
17. Leary SP, Regan JJ, Lanman TH, Wagner WH (2007) Revision
and explantation strategies involving the CHARITE lumbar
artificial disc replacement. Spine 32(9):1001–1011
18. Spivak JM, Petrizzo AM (2010) Revision of a lumbar disc
arthroplasty following late infection. Eur Spine J 19(5):677–681
19. Tiusanen H, Seitsalo S, Osterman K, Soini J (1995) Retrograde
ejaculation after anterior interbody lumbar fusion. Eur Spine J
4(6):339–342
2564 Eur Spine J (2012) 21:2558–2564
123
